For Research Use Only. We do not provide direct services or products for patients.
Product Overview
Recombinant monoclonal antibody to NRP1. Vesencumab, which binds to neuropilin 1, is an immunomodulator designed for the treatment of solid malignancies.
Target
SARS-CoV-2
Source
CHO cells
Clonality
MAb
Isotype
IgG1-kappa
Concertration
1 mg/ml
Immunogen
NRP1
Type
Antibody
Form
Liquid
Buffer Solution
PBS, pH 7.5.
Applications
Used for WB, ELISA, IHC-P, FCM, ICC/IF, IP.
Storage
Store at 2°C to 8°C short term, -20°C long term.
Introduction
Vesencumab is under investigation in clinical trial NCT00747734 (A Study of MNRP1685A in Patients With Locally Advanced or Metastatic Solid Tumors).